Literature DB >> 15802895

Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.

A A N Giagounidis1, S Haase, U Germing, M Heinsch, C Aul.   

Abstract

Autoimmune diseases occurring concurrently with myelodysplastic syndrome (MDS) with deletion del(5q) including band q31 are very rare and have only been reported twice in the medical literature. We present two additional cases, one patient with del(5q) and trisomy 21 who suffered from rheumatoid arthritis and one patient with isolated del(5q) and autoimmune hemolytic anemia. Both patients had mild leukopenia and severe transfusion-dependent anemia. The rheumatoid arthritis was treated with antirheumatics without additional immunosuppressive medication. Autoimmune hemolytic anemia was controlled with long-term steroid administration. This patient developed additional trisomy 21, 2 years after the initial diagnosis of del(5q). Contrary to previous reports on autoimmune disorders in MDS mentioning improvements of hematological function in response to steroid administration, neither of our patients had a hematological improvement under corticosteroids. Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802895     DOI: 10.1159/000083454

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

1.  [Rationale for bone marrow examination in patients with inflammatory rheumatic diseases].

Authors:  Jutta G Richter; Pascal Gossen; Ulrich Germing; Sabine Blum; Barbara Hildebrandt; Stefan Braunstein; Dörte Huscher; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Authors:  Omar Al Ustwani; Laurie A Ford; Sheila J N Sait; Anne Marie W Block; Maurice Barcos; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Julian Ambrus; Meir Wetzler
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

3.  Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome.

Authors:  Yoon-Jeong Oh; Dong-Yeop Shin; Sang Mee Hwang; Sung-Min Kim; Kyongok Im; Hee Sue Park; Jung-Ah Kim; Yeong Wook Song; Ana Márquez; Javier Martín; Dong-Soon Lee; Jin Kyun Park
Journal:  Korean J Intern Med       Date:  2019-10-25       Impact factor: 2.884

4.  Risks of myeloid malignancies in patients with autoimmune conditions.

Authors:  L A Anderson; R M Pfeiffer; O Landgren; S Gadalla; S I Berndt; E A Engels
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

Review 5.  Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.

Authors:  Arsène Mekinian; Thorsten Braun; Olivier Decaux; Géraldine Falgarone; Eric Toussirot; Loic Raffray; Mohamed Omouri; Bruno Gombert; Benoit De Wazieres; Anne-Laure Buchdaul; Jean-Marc Ziza; David Launay; Guillaume Denis; Serge Madaule; Christian Rose; Eric Grignano; Pierre Fenaux; Olivier Fain
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

6.  Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report.

Authors:  Gerasimos Evangelatos; Ioanna Vlachadami; Maria Kechagia; Alexios Iliopoulos
Journal:  Mediterr J Rheumatol       Date:  2017-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.